Although she's not an entomologist, Maggie Stanislawski, Ph.D., spends hours a day studying bugs. The assistant professor of biomedical informatics specializes in the gut microbiome, an environment ...
Espresso on MSN
Colon cancer: Warning signs you shouldn’t ignore
Here’s what you need to know about colon cancer, and what you can do to prevent it from affecting your life or the lives of ...
Five years ago, Tim Cannon, a cancer doctor in Virginia, saw that his colon cancer patients were getting younger and their cancer was more aggressive. He had just diagnosed three people in their 30s ...
Researchers have created tiny metal-based particles that push cancer cells over the edge while leaving healthy cells mostly unharmed. The particles work by increasing internal stress in cancer cells ...
Marissa Sulek joined CBS News Chicago in January 2025. Before Chicago, Marissa was a general assignment reporter in Nashville at WSMV, where she was nominated for Mid-South Emmy Awards for her ...
Across the country, raising the minimum wage continues to be a topic of conversation. Some claim that raising the minimum wage to $20 would help both low-income employees as well as employers. Though ...
The MarketWatch News Department was not involved in the creation of this content. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--December 18, 2025-- Cartography Biosciences, Inc., a biotechnology ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., a biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced that the ...
Cartography Biosciences, Inc., a biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has ...
A teenager in New Mexico has been charged with first-degree murder after he allegedly recruited his friend to shoot his parents to death, so they could split his inheritance money, according to police ...
Adagene Inc. ADAG announced that the FDA has granted Fast Track designation to its lead clinical-stage immuno-oncology candidate, muzastotug (ADG126). The designation was granted to muzastotug in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback